RecruitingPhase 4NCT07084402
Short-term Bactericidal Effect of Contezolid in MAC-PD
Studying Pulmonary non-tuberculous mycobacterial infection
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bin Cao
- Principal Investigator
- Xiaojing Cui, M.D.China-Japan Friendship Hospital
- Intervention
- Contezolid(drug)
- Enrollment
- 188 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2025 – 2027
Study locations (3)
- Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- China-Japan Friendship Hospital, Beijing, Beijing Municipality, China
- Jiangxi Provincial Chest Hospital, Nanchang, Jiangxi, China
Collaborators
Beijing Chest Hospital, Capital Medical University · Jiangxi Provincial Chest Hospital · MicuRx
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07084402 on ClinicalTrials.govOther trials for Pulmonary non-tuberculous mycobacterial infection
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE1NCT07228702Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionVancouver Coastal Health
- RECRUITINGNANCT07192705Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)University College, London
- RECRUITINGPHASE4NCT07213765Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary DiseaseBin Cao
- RECRUITINGPHASE4NCT07174076Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary DiseaseBin Cao
- RECRUITINGNCT07131774Treatment Monitoring for NTM Infections With a Symptom DiaryResearch Center Borstel
- RECRUITINGNCT06815588Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment MonitoringResearch Center Borstel
- RECRUITINGNCT05906316A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative StudyRadboud University Medical Center
- RECRUITINGNCT05824988Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung DiseaseShanghai Pulmonary Hospital, Shanghai, China
See all trials for Pulmonary non-tuberculous mycobacterial infection →